FDA expands use of Sapien 3 artificial heart valve for high-risk patients - FDA.gov

Reuters

FDA expands use of Sapien 3 artificial heart valve for high-risk patients FDA.gov The U.S. Food and Drug Administration today approved an expanded indication for the Sapien 3 Transcatheter Heart Valve (THV) for patients with symptomatic heart disease due to failure of a previously placed bioprosthetic aortic or mitral valve whose ... FDA Okays Sapien 3 for Mitral, Aortic Valve-in-Valve ReplacementMedscape Balloon-expandable valve receives FDA approval for aortic, mitral valve-in-valve proceduresHealio all 6 news articles »

from Health - Google News http://ift.tt/2qVjk85